ArticleCureus2025
Cerebral Small Vessel Disease: Bystander or Culprit?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral small vessel disease (SVD) contributes to about 45% of dementias and causes substantial cognitive, psychiatric, and physical disability. The most common form of monogenic strokes is cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), which is caused by mutations in the NOTCH3 gene. This leads to cerebrovascular NOTCH3 protein aggregation and compromises cerebral blood flow. We present the case of a 69-year-old female patient presenting with dysarthria, a past medical history of migraines, and a family history of early-onset stroke. She was treated at a large district general hospital. Non-contrast computed tomography (CT) brain showed changes in keeping with small vessel ischaemic change. Subsequent magnetic resonance imaging (MRI) revealed an acute right frontal lobe infarct with extensive high signal intensity changes. Involvement of the temporal lobes suggested CADASIL as a possible differential diagnosis. The genetic testing confirmed a heterozygous pathogenic NOTCH3 variant. This case highlights the importance of testing for CADASIL in patients with extensive SVD changes coupled with a history of stroke at an early age or family history of strokes. Informed written consent was obtained from the patient to publish her clinical information anonymously.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.